Skip to main content

Table 1 Clinical characteristics and hormonal profiles of the control and polycystic ovarian syndrome (PCOS) group

From: Women with polycystic ovary syndrome (PCOS) have reduced melatonin concentrations in their follicles and have mild sleep disturbances

 

Controls

(n = 36)

PCOS

(n = 35)

p value

Age (years)

28.063 ± 1.000

26.926 ± 1.000

0.094

Infertility years (years)

3 (2–4)

2 (1–4)

0.280

BMI (kg/m2)

21.134 ± 0.081

22.333 ± 0.154

0.119

FSH (IU/L)

6.216 ± 1.602

5.998 ± 1.193

0.542

LH (IU/L)

4.085 (3.235–5.773)

8.090 (5.940–15.110)

< 0.001***

LH/FSH

0.636 ± 1.907

1.462 ± 1.757

< 0.001***

Estradiol (pg/ml)

38.845 (30.750–55.250)

47.000 (39.598–69.695)

0.048*

Progesterone (ng/ml)

0.239 ± 0.140

0.248 ± 0.029

0.837

Testosterone (ng/ml)

0.914 ± 0.441

1.407 ± 0.519

0.020*

AMH (ng/ml)

3.506 (2.650–4.813)

8.825 (5.868–12.190)

< 0.001***

Intrafollicular Melatonin (pg/ml)

54.455 ± 1.303

49.137 ± 1.151

0.045*

  1. *p < 0.05; ***p < 0.001